2022
Exports
$7.57BWorld Rnk 9 / 208
Flag Rnk 5 / 1214
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$8.13BWorld Rnk 11 / 225
Flag Rnk 7 / 1214
2022
ECONOMIC COMPLEXITY of Spain
0.81Rnk 33 / 133

About

Exports In 2022, Spain exported $7.57B in Vaccines, blood, antisera, toxins and cultures, making it the 9th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Spain. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Spain are: Japan ($2.71B), Singapore ($673M), Ireland ($639M), United States ($575M), and Germany ($556M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Spain between 2021 and 2022 were Japan ($2.42B), Singapore ($666M), and Germany ($203M).

Imports In 2022, Spain imported $8.13B in Vaccines, blood, antisera, toxins and cultures, becoming the 11th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in Spain. Spain imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($2.62B), Germany ($1.37B), United States ($1.24B), Belgium ($1.2B), and Netherlands ($683M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Spain between 2021 and 2022 were Belgium ($180M), Netherlands ($66.4M), and Poland ($52M).

Latest Trends

September 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (September 2023 - September 2024)€-13M(-3.72%)
IMPORT GROWTH (September 2023 - September 2024)€147M(28.4%)
MAIN EXPORTER (September 2024)Madrid€214M
MAIN DESTINATION (September 2024)Belgium€134M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Spain. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$7.57B
IMPORTS (2022)$8.13B
NET TRADE (2022)-$564M

In 2022, Spain exported $7.57B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Spain exports on Vaccines, blood, antisera, toxins and cultures were Japan ($2.71B), Singapore ($673M), Ireland ($639M), United States ($575M), and Germany ($556M).

In 2022, Spain imported $8.13B in Vaccines, blood, antisera, toxins and cultures, mainly from Switzerland ($2.62B), Germany ($1.37B), United States ($1.24B), Belgium ($1.2B), and Netherlands ($683M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Spain WERE (2021 - 2022):
Japan$2.42B (811%)
Singapore$666M (9.28k%)
Germany$203M (57.4%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Spain WERE (2021 - 2022):
Belgium-$4.24B (-98.4%)
Pakistan-$337M (-99.3%)
Canada-$217M (-94.4%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Spain's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Spain's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $393M
TOP IMPORT POTENTIALGermany+ $230M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $393M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $230M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with